U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07302802) titled 'Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monogenic Obesity in Clinical Practice' on Dec. 10.
Brief Summary: This observational study aims to assess the effect of once-weekly s.c. semaglutide 2.4 mg as an adjunct to a calorie-reduced diet and increased physical activity on weight loss, change in hunger, body composition, depression, and quality of life after 68 weeks of treatment in adolescents diagnosed with monogenic obesity in routine clinical care.
Study Start Date: Dec. 01
Study Type: OBSERVATIONAL
Condition:
Monogenic Obesity
Intervention:
DRUG: Semaglutide (administered b...